Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Exempts urological and ostomy supplies from Medicare competitive bidding for five years.
The problem
Medicare uses competitive bidding to lower costs on medical supplies. Some argue this process has harmed access to urological and ostomy supplies for patients.
The proposal
The bill prevents urological and ostomy supplies from being included in Medicare's competitive acquisition programs for five years, allowing prices and supply chains to operate differently.
The impact
Medicare beneficiaries using urological and ostomy supplies, medical suppliers, manufacturers, and Medicare's budget are affected by pricing and availability changes.
Removing these supplies from competitive bidding may ensure beneficiaries have consistent access to necessary products. Patients with serious medical needs could avoid supply shortages or long delays.
Medical suppliers specializing in urological and ostomy products may maintain more stable operations and inventory. Smaller suppliers might stay in business rather than being undercut by larger competitors.
Without competitive price pressure, companies may invest more in product quality and new innovations. Better products could improve patients' health and quality of life.
Five-year exemption could reduce administrative complexity for providers and patients seeking these supplies. Fewer delays in obtaining necessary medical equipment.
Without competitive bidding, prices may be higher than market rates would allow. This increases spending from the Medicare program, affecting the program's long-term solvency.
Exempting these supplies removes incentives for suppliers to compete on price and efficiency. This could allow prices to stay artificially high compared to other market conditions.
Approving this five-year exemption may encourage other medical product manufacturers to seek similar protections. This could expand non-competitive pricing across many Medicare-covered items.
Higher Medicare costs may strain federal budgets and require increased beneficiary premiums or reduced benefits elsewhere. Taxpayers ultimately bear the cost of higher program spending.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.